Cazzola M - Search Results

1

Bronchodilating effects of salmeterol, theophylline and their combination in patients with moderate to severe asthma.

Vatrella A, Ponticiello A, Pelaia G, Parrella R, Cazzola M. Vatrella A, et al. Among authors: cazzola m. Pulm Pharmacol Ther. 2005;18(2):89-92. doi: 10.1016/j.pupt.2004.09.033. Epub 2004 Dec 8. Pulm Pharmacol Ther. 2005. PMID: 15649850 Clinical Trial.

2

An M1-selective muscarinic receptor antagonist telenzepine improves lung function in patients with chronic obstructive bronchitis.

Cazzola M, D'Amato G, Guidetti E, Staudinger H, Steinijans VW, Kilian U. Cazzola M, et al. Pulm Pharmacol. 1990;3(4):185-9. doi: 10.1016/0952-0600(90)90015-b. Pulm Pharmacol. 1990. PMID: 2135223 Clinical Trial.

3

Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study.

Cazzola M, Matera MG, Santangelo G, Vinciguerra A, Rossi F, D'Amato G. Cazzola M, et al. Respir Med. 1995 May;89(5):357-62. doi: 10.1016/0954-6111(95)90008-x. Respir Med. 1995. PMID: 7638371 Free article. Clinical Trial.

4

Effect of salmeterol and formoterol in patients with chronic obstructive pulmonary disease.

Cazzola M, Santangelo G, Piccolo A, Salzillo A, Matera MG, D'Amato G, Rossi F. Cazzola M, et al. Pulm Pharmacol. 1994 Apr;7(2):103-7. doi: 10.1006/pulp.1994.1012. Pulm Pharmacol. 1994. PMID: 7915921 Clinical Trial.

5

Effect of telenzepine, an M1-selective muscarinic receptor antagonist, in patients with nocturnal asthma.

Cazzola M, Matera MG, Liccardi G, Sacerdoti G, D'Amato G, Rossi F. Cazzola M, et al. Pulm Pharmacol. 1994 Apr;7(2):91-7. doi: 10.1006/pulp.1994.1010. Pulm Pharmacol. 1994. PMID: 8081076 Clinical Trial.

6

A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease.

Matera MG, Cazzola M, Vinciguerra A, Di Perna F, Calderaro F, Caputi M, Rossi F. Matera MG, et al. Among authors: cazzola m. Pulm Pharmacol. 1995 Dec;8(6):267-71. doi: 10.1006/pulp.1995.1036. Pulm Pharmacol. 1995. PMID: 8819181 Clinical Trial.

7

A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease.

Matera MG, Caputi M, Cazzola M. Matera MG, et al. Among authors: cazzola m. Respir Med. 1996 Sep;90(8):497-9. doi: 10.1016/s0954-6111(96)90178-x. Respir Med. 1996. PMID: 8869445 Free article. Clinical Trial. No abstract available.

8

The use of bronchodilators in stable chronic obstructive pulmonary disease.

Cazzola M, Spina D, Matera MG. Cazzola M, et al. Pulm Pharmacol Ther. 1997 Jun;10(3):129-44. doi: 10.1006/pupt.1997.0087. Pulm Pharmacol Ther. 1997. PMID: 9514624 Review. No abstract available.

9

A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease.

Cazzola M, Matera MG, Di Perna F, Calderaro F, Califano C, Vinciguerra A. Cazzola M, et al. Respir Med. 1998 Feb;92(2):354-7. doi: 10.1016/s0954-6111(98)90121-4. Respir Med. 1998. PMID: 9616538 Free article. Clinical Trial.

10

Early reversibility to salbutamol does not always predict bronchodilation after salmeterol in stable chronic obstructive pulmonary disease.

Cazzola M, Vinciguerra A, Di Perna F, Matera MG. Cazzola M, et al. Respir Med. 1998 Aug;92(8):1012-6. doi: 10.1016/s0954-6111(98)90347-x. Respir Med. 1998. PMID: 9893768 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,246 results

Search Page

Filters